Filing Flows › Retractable Technologies (RVP) › Q2 2026
Retractable Technologies (RVP) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 14, 2026
Retractable Technologies (RVP) reported revenue of $7.2M for the second quarter 2026 (Q2 2026), -31% from a year earlier and +0.3% from the quarter before. Operating margin was -71.5%, net earnings $2.8M (39.3% of revenue).
Retractable Technologies, Q2 2026: revenue $7.2M (-31% year over year), operating margin -71.5%, net earnings $2.8M, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.2M | +0.3% | -31% |
| Operating profit | −$5.1M | — | — |
| Net earnings | $2.8M | — | — |
| Operating cash flow | −$1.7M | — | — |
What changed
Revenue was $7.2M in Q2 2026, down 31% year over year and roughly flat from the previous quarter. Syringes was the largest line at 87% of revenue. EasyPoint Needles lost $3.5M year over year (down 85%), 109% of the total change.
Gross margin was 2.7%. Operating costs exceeded revenue by $5.1M, an operating margin of -71.5%. The fastest-growing cost line was Research & development (+17%). Net earnings were $2.8M. The effective tax rate was 0.1%. Non-operating items added $8.0M, 282% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$1.7M. Non-cash charges added back $1.9M of depreciation and amortization. Working capital and other items used $6.5M. Capital expenditures of $30K exceeded it, leaving free cash flow of −$1.8M.
Questions
What was Retractable Technologies' revenue in the second quarter 2026?
Retractable Technologies (RVP) reported revenue of $7.2M for the second quarter 2026 (Q2 2026), -31% from a year earlier and +0.3% from the quarter before.
Was Retractable Technologies profitable in the second quarter 2026?
Operating loss was $5.1M (-71.5% of revenue) and net earnings $2.8M.